Division of Surgery, The Alfred Hospital, Melbourne, Victoria, Australia.
Division of Cancer Surgery, Peter MacCallum Cancer Centre, Victorian Comprehensive Cancer Centre, Melbourne, Victoria, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia; Department of Digestive Surgery, Pontificia Universidad Católica de Chile, Santiago, Chile.
Eur J Surg Oncol. 2022 Nov;48(11):2330-2337. doi: 10.1016/j.ejso.2022.08.004. Epub 2022 Aug 17.
Minimally invasive surgical techniques are being successfully used to treat locally advanced and recurrent pelvic malignancy of colorectal origin. This review aims to describe the application of minimally invasive approaches to pelvic exenteration and compare current reported surgical outcomes.
A literature search was performed of PubMed, Google Scholar and EMBASE for studies on pelvic exenteration with locally advanced or recurrent rectal cancer utilising minimally invasive techniques. A total of 22 studies were reviewed, including four case reports describing novel approaches.
Laparoscopic, robotic and trans-anal total mesenteric excision (TaTME) aided pelvic exenteration methods have recently demonstrated low post-operative morbidity and mortality trends. Minimally invasive methods also have improved rates of R0 resection in modest cohort studies. Hybrid methods have also been proposed to overcome observed technical difficulties such as the narrow male pelvis and obese habitus. There is still limited data beyond case report and small cohort studies on challenging patient groups such as those with recurrent rectal cancer or bony involvement, as a consequence of patient selection for these novel approaches.
International, multicentre studies have provided the best opportunity to explore efficacy of these methods on a larger scale. Further research is required into patient selection, safety and long-term outcomes of these approaches within high volume centres practicing beyond the surgical learning curve.
微创外科技术正成功地用于治疗结直肠来源的局部晚期和复发性盆腔恶性肿瘤。本综述旨在描述微创方法在盆腔廓清术中的应用,并比较目前报道的手术结果。
对 PubMed、Google Scholar 和 EMBASE 中的文献进行了检索,以查找利用微创技术治疗局部晚期或复发性直肠肿瘤的盆腔廓清术研究。共回顾了 22 项研究,包括 4 篇描述新方法的病例报告。
腹腔镜、机器人和经肛门全肠系膜切除(TaTME)辅助的盆腔廓清术方法最近显示出较低的术后发病率和死亡率趋势。微创方法也在适度的队列研究中提高了 R0 切除率。杂交方法也被提出以克服观察到的技术困难,如男性骨盆狭窄和肥胖体型。由于对这些新方法的患者选择,对于具有复发性直肠癌或骨受累等挑战性患者群体的研究,仍仅限于病例报告和小队列研究,数据有限。
国际多中心研究为更大规模地探讨这些方法的疗效提供了最佳机会。需要在实践超过手术学习曲线的高容量中心内,对这些方法的患者选择、安全性和长期结果进行进一步研究。